Literature DB >> 10870800

Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism.

M D McColl1, N Sattar, J Ellison, R C Tait, I D Walker, C J Packard, I A Greer.   

Abstract

Plasma concentrations of lipoprotein (a), total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglyceride were measured in 62 women who had suffered an episode of objectively confirmed venous thromboembolism (VTE) at < or = 50 years of age, and in 98 age-matched female controls. The mean body mass index (BMI) of cases was significantly (P < 0.001) higher than that of controls. Plasma triglyceride was significantly higher, and total cholesterol/LDL- and HDL-cholesterol significantly lower, in cases compared with controls. After adjustment for BMI, the plasma total cholesterol and LDL-cholesterol remained significantly lower in cases. No significant differences in mean plasma lipoprotein (a) levels were identified between cases and controls. Lipoprotein (a) does not appear to be significantly associated with the development of VTE in young women. The increased risk of VTE in obese subjects may be mediated, at least in part, via hypertriglyceridaemia, which has previously been demonstrated to have effects on levels of coagulation factors, natural anticoagulants, and plasminogen activator inhibitor type 1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10870800

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  11 in total

1.  Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.

Authors:  B M Everett; R J Glynn; J E Buring; P M Ridker
Journal:  J Thromb Haemost       Date:  2009-01-24       Impact factor: 5.824

2.  High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Alanna M Chamberlain; Aaron R Folsom; Susan R Heckbert; Wayne D Rosamond; Mary Cushman
Journal:  Blood       Date:  2008-07-09       Impact factor: 22.113

Review 3.  Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France.

Authors:  Farid Menaa; Abder Menaa; Bouzid Menaa; Jacques Tréton
Journal:  Eur J Nutr       Date:  2012-12-27       Impact factor: 5.614

4.  The role of dyslipidemia and statins in venous thromboembolism.

Authors:  Joel G Ray; Frits R Rosendaal
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

5.  Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.

Authors:  Elena Sticchi; Alberto Magi; Pia R Kamstrup; Rossella Marcucci; Domenico Prisco; Ida Martinelli; Pier Mannuccio Mannucci; Rosanna Abbate; Betti Giusti
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

6.  Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis.

Authors:  Xia Jiang; Oana A Zeleznik; Sara Lindström; Jessica Lasky-Su; Kaitlin Hagan; Clary B Clish; A Heather Eliassen; Peter Kraft; Christopher Kabrhel
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

7.  Influence of lipid metabolism disorders on venous thrombosis risk.

Authors:  Igor Spasić; Milan Ubavić; Zorica Šumarac; Maša Todorović; Biljana Vučković
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

Review 8.  Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis.

Authors:  Yuhong Mi; Shufeng Yan; Yanhui Lu; Ying Liang; Chunsheng Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Authors:  John Gregson; Stephen Kaptoge; Thomas Bolton; Lisa Pennells; Peter Willeit; Stephen Burgess; Steven Bell; Michael Sweeting; Eric B Rimm; Christopher Kabrhel; Bengt Zöller; Gerd Assmann; Vilmundur Gudnason; Aaron R Folsom; Volker Arndt; Astrid Fletcher; Paul E Norman; Børge G Nordestgaard; Akihiko Kitamura; Bakhtawar K Mahmoodi; Peter H Whincup; Matthew Knuiman; Veikko Salomaa; Christa Meisinger; Wolfgang Koenig; Maryam Kavousi; Henry Völzke; Jackie A Cooper; Toshiharu Ninomiya; Edoardo Casiglia; Beatriz Rodriguez; Yoav Ben-Shlomo; Jean-Pierre Després; Leon Simons; Elizabeth Barrett-Connor; Cecilia Björkelund; Marlene Notdurfter; Daan Kromhout; Jackie Price; Susan E Sutherland; Johan Sundström; Jussi Kauhanen; John Gallacher; Joline W J Beulens; Rachel Dankner; Cyrus Cooper; Simona Giampaoli; Jason F Deen; Agustín Gómez de la Cámara; Lewis H Kuller; Annika Rosengren; Peter J Svensson; Dorothea Nagel; Carlos J Crespo; Hermann Brenner; Juan R Albertorio-Diaz; Robert Atkins; Eric J Brunner; Martin Shipley; Inger Njølstad; Deborah A Lawlor; Yvonne T van der Schouw; Randi Marie Selmer; Maurizio Trevisan; W M Monique Verschuren; Philip Greenland; Sylvia Wassertheil-Smoller; Gordon D O Lowe; Angela M Wood; Adam S Butterworth; Simon G Thompson; John Danesh; Emanuele Di Angelantonio; Tom Meade
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

10.  Risk of Stroke in Patients With Patent Foramen Ovale Who Had Pulmonary Embolism.

Authors:  Satyajeet Roy; Han Le; Ayobamidele Balogun; Elizabeth Caskey; Thomas Tessitore; Rasagnya Kota; Janice Hejirika; Siyuan Yu; Long Nguyen; Andrew Louis Lazo; Christopher Yard; Michael Monaghan; Menaka Dhingra; Sneha Modi; Krystal Hunter
Journal:  J Clin Med Res       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.